Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial

被引：30

作者：

Veien, NK

Busch-Sorensen, M

Stausbol-Gron, B

机构：

[1] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark

[2] Dermatol Clin, DK-9000 Aalborg, Denmark

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 53卷 / 01期

关键词：

D O I：

10.1016/j.jaad.2004.12.011

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In a randomized, double-blind, placebo-controlled 4-week trial, 59 patients with moderate to severe atopic dermatitis were treated orally with 10 mg of the leukoriene antagonist montelukast. Forty-seven patients completed the study. No difference in efficacy was seen among patients who received montelukast and the group given a placebo.

引用

下载

页码：147 / 149

页数：3

共 50 条

[1] The effect of dupilumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
Blauvelt, A.
Simpson, E.
Wu, R.
Akinlade, B.
Graham, N.
Pirozzi, G.
Evans, R.
ALLERGY, 2016, 71 : 95 - 95
[2] Randomized, double-blind, placebo-controlled trial of buspirone in atopic dermatitis.
Sharpe, RJ
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 209 - 209
[3] A double-blind, placebo-controlled trial of montelukast in adult atopic eczema
Friedmann, P. S.
Palmer, R.
Tan, E.
Ogboli, M.
Barclay, G.
Hotchkiss, K.
Berth-Jones, J.
CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (10): : 1536 - 1540
[4] Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis:: a randomized, double-blind, placebo-controlled trial
Berth-Jones, J.
Arkwright, P. D.
Marasovic, D.
Savani, N.
Aldridge, C. R.
Leech, S. N.
Morgan, C.
Clark, S. M.
Ogilvie, S.
Chopra, S.
Harper, J. I.
Smith, C. H.
Rook, G. A. W.
Friedmann, P. S.
CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (09): : 1115 - 1121
[5] A new treatment for atopic dermatitis: a randomized double-blind placebo-controlled study
Freeman, S
Day, R
Williams, K
Liauw, W
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB3 - AB3
[6] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF SYSTEMIC FLUNISOLIDE IN THE TREATMENT OF CHILDREN WITH SEVERE ATOPIC-DERMATITIS
LAROSA, E
MUSARRA, I
RANNO, C
MAIELLO, N
NEGRI, L
DELGIUDICE, MM
OGGIANO, N
KANTAR, A
FABBRIZI, E
BARBERIO, G
PAJNO, GB
CAVAGNI, G
CAFFARELLI, C
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (07): : 720 - 726
[7] Efficacy of Individualized Homeopathic Medicines in the Treatment of Atopic Dermatitis in Adults: A Double-Blind, Randomized, Placebo-Controlled, Preliminary Trial
Dey, Samit
Shaikh, Abdur Rahaman
Saha, Sangita
Agrawal, Ekta
Gautam, Ashish Kumar
Karuppusamy, Avaranjika
Sadhukhan, Satarupa
Dutta, Souvik
Ali, Sk. Swaif
Basu, Anamika
Koley, Munmun
Saha, Subhranil
COMPLEMENTARY MEDICINE RESEARCH, 2022, 29 (01) : 17 - 26
[8] Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial
Berth-Jones, J
Takwale, A
Tan, E
Barclay, G
Agarwal, S
Ahmed, I
Hotchkiss, K
Graham-Brown, RAC
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 324 - 330
[9] The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial
Mehrbani, Mehrzad
Choopani, Rasool
Fekri, Alireza
Mehrabani, Mitra
Mosaddegh, Mahmoud
Mehrabani, Mehrnaz
JOURNAL OF ETHNOPHARMACOLOGY, 2015, 172 : 325 - 332
[10] Azathioprine in severe adult atopic dermatitis: A double-blind, placebo-controlled, crossover trial
Graham-Brown, RA
Takwale, A
Tan, E
Barclay, G
Agarwal, S
Ahmed, I
Hotchkiss, K
Berth-Jones, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 343 - 343

← 1 2 3 4 5 →